Lineage dependency and lineage-survival oncogenes in human cancer
- PMID: 16862190
- DOI: 10.1038/nrc1947
Lineage dependency and lineage-survival oncogenes in human cancer
Erratum in
- Nat Rev Cancer. 2006 Sep;6(9):742
Abstract
Although cell-lineage and differentiation models dominate tumour classification and treatment, the recognition that cancer is also a genomic disease has prompted a reconfiguration of cancer taxonomies according to molecular criteria. Recent evidence indicates that a synthesis of lineage-based and genetic paradigms might offer new insights into crucial and therapeutically pliable tumour dependencies. For example, MITF (microphthalmia-associated transcription factor), which is a master regulator of the melanocyte lineage, might become a melanoma oncogene when deregulated in certain genetic contexts. MITF and other lineage-survival genes therefore implicate lineage dependency (or lineage addiction) as a newly recognized mechanism that is affected by tumour genetic alterations.
Similar articles
-
"Lineage addiction" in human cancer: lessons from integrated genomics.Cold Spring Harb Symp Quant Biol. 2005;70:25-34. doi: 10.1101/sqb.2005.70.016. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869735
-
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.Nature. 2005 Jul 7;436(7047):117-22. doi: 10.1038/nature03664. Nature. 2005. PMID: 16001072
-
From integrated genomics to tumor lineage dependency.Cancer Res. 2006 Mar 1;66(5):2506-8. doi: 10.1158/0008-5472.CAN-05-4604. Cancer Res. 2006. PMID: 16510564 Review.
-
Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.Cancer Res. 2008 May 1;68(9):3124-32. doi: 10.1158/0008-5472.CAN-07-6622. Cancer Res. 2008. PMID: 18451137
-
Pro-survival role of MITF in melanoma.J Invest Dermatol. 2015 Feb;135(2):352-358. doi: 10.1038/jid.2014.319. Epub 2014 Aug 21. J Invest Dermatol. 2015. PMID: 25142731 Review.
Cited by
-
Current status and perspectives of patient-derived rare cancer models.Hum Cell. 2020 Oct;33(4):919-929. doi: 10.1007/s13577-020-00391-1. Epub 2020 Jun 14. Hum Cell. 2020. PMID: 32537685 Review.
-
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.Nature. 2012 Oct 4;490(7418):116-20. doi: 10.1038/nature11378. Epub 2012 Aug 12. Nature. 2012. PMID: 22885699 Free PMC article.
-
A multiscale model of the role of microenvironmental factors in cell segregation and heterogeneity in breast cancer development.PLoS Comput Biol. 2023 Nov 22;19(11):e1011673. doi: 10.1371/journal.pcbi.1011673. eCollection 2023 Nov. PLoS Comput Biol. 2023. PMID: 37992135 Free PMC article.
-
Current Status and Perspectives of Patient-Derived Models for Ewing's Sarcoma.Cancers (Basel). 2020 Sep 4;12(9):2520. doi: 10.3390/cancers12092520. Cancers (Basel). 2020. PMID: 32899796 Free PMC article.
-
Building a framework for embryonic microenvironments and cancer stem cells.Stem Cell Rev Rep. 2009 Dec;5(4):319-27. doi: 10.1007/s12015-009-9096-7. Stem Cell Rev Rep. 2009. PMID: 20058196 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources